Total Results: 15738

Senate Republicans Reject Democrats’ Effort To Block Obamacare Repeal Resolution

KHN Morning Briefing

Democrats fail in their attempt to offer an amendment to the budget resolution that would have prevented the chamber from taking up legislation to raise health insurance premiums or out-of-pocket costs. But what has become clear is that some of Congress’s most stalwart conservatives are signalling their readiness to support a budget that would add more than $1 trillion to the deficit by the end of the decade. Sen. Rand Paul, R-Ky., is not among them and is pressing members of the House Freedom Caucus to join him in the opposition.

Likely On Way Out, FDA Chief Defends Drug Effectiveness

KHN Morning Briefing

Elsewhere, fewer drugs were approved this year, critics worry the 21st Century Cures Act could make patients more vulnerable and insurers change how they pay for insulin after higher prices.

Obamacare’s Reach Could Make Dismantling A Difficult Task

KHN Morning Briefing

Even as congressional Republicans set to work on making good on their promise to repeal and replace the health law, the past eight years of Obamacare have meant that it has touched much of the nation’s health system and the efforts to undo it will raise a variety of issues, including those about the insurance marketplace.

Pelosi Marshals Dems Into National Day Of Action To Defend Health Law

KHN Morning Briefing

The House Democratic leader wants lawmakers to “continue the drumbeat” back in their districts about how much the health law benefits their constituents. Meanwhile, Donald Trump doesn’t need Congress to be able to end the subsidies paid to insurers under the health law — and it could throw the market into chaos if he chooses to take that route.

Drugmakers’ ‘Predatory’ Pricing Model Slammed In Congressional Committee Report

KHN Morning Briefing

The report from the Senate Aging Committee presents four case studies and identifies what are described as five “essential elements” of the business models used by drugmakers to exploit the market for their medicines: price gouging, a sole-source supply, the “gold standard,” a small market and a closed distribution system.